Multiple Sclerosis Journal

Titel Veröffentlichungsdatum Sprache Zitate
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study2024/03/13English
Non-inferiority analysis of subcutaneous versus intravenous 300 mg monthly natalizumab administration: A post hoc analysis of the REFINE study2024/03/13English
Autologous hematopoietic stem cells transplantation in MOGAD2024/03/25English
Torben Fog – A Danish pioneer in a multi-faceted spectrum of multiple sclerosis research2024/03/24English
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society2024/02/15English
A custom-built step exergame training programme to prevent falls in people with multiple sclerosis: A multicentre randomised controlled trial2024/02/16English
What doesn’t kill you makes you stronger . . . or does it?2024/02/17English
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis2023/02/19English
Comparative effectiveness of natalizumab on cognition in multiple sclerosis: A cohort study2023/02/15English
The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosis2024/01/23English
Breakthrough COVID-19 infection in people with MS after SARS-CoV-2 vaccination: Should we still be concerned?2023/07/01English
Long-term trajectories of ambulatory impairment in multiple sclerosis2023/07/28English
Radiologically isolated syndrome in the spectrum of multiple sclerosis2024/04/15English
Prevalence and incidence of multiple sclerosis in Turkey: A nationwide epidemiologic study2024/04/14English
Multiple sclerosis can be diagnosed solely with dissemination in space: Commentary2024/04/14English
Multiple sclerosis can be diagnosed solely with dissemination in space: Yes2024/04/14English
Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS2024/04/15English
Multiple sclerosis can be diagnosed solely with dissemination in space: No2024/04/14English
Therapeutic lag: Is treatment effect delayed in progressive MS?2024/04/14English
Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein–associated disease2024/04/22English
Extended interval dosing with ocrelizumab in multiple sclerosis2024/04/22English
What contributes to disability in progressive MS? A brain and cervical cord–matched quantitative MRI study2024/02/19English
2.5-Year changes of connectivity dynamism are relevant for physical and cognitive deterioration in multiple sclerosis2024/02/19English
Eye movement desensitization and reprocessing for depressed individuals with multiple sclerosis: A pilot study2024/02/19English
A US payer perspective health economic model assessing value of monitoring disease activity to inform discontinuation and re-initiation of DMT in multiple sclerosis2024/02/19English
Clinical commentary on ‘Cortical ischemic lesions from atrial myxoma as a mimic of disease activity in a RRMS antiCD20-treated patient’2023/09/15English
Therapy challenges for NMOSD in a patient with HIV2023/09/15English
Arterial stiffness in persons with multiple sclerosis and controls: Does aerobic fitness account for group differences?2023/09/11English
Pseudocystic demyelination in multiple sclerosis2023/08/25English
Clinical and radiologic characteristics associated with multiple sclerosis misdiagnosis at a tertiary referral center in the United States2023/09/12English